4922
This same AR mutation has been reported previously in a metastatic prostate cancer cell line , LNCaP , where this mutation confers upon the AR an altered ligand - binding specificity which is stimulated by estrogens , progestagens , and antiandrogens .
 Disease: metastatic prostate cancer
Given options, please tell me the categories of all the listed entity words.Output format is "type1: word1; type2: word2". 
Option: Disease 
Text: {0} 
 Entities: metastatic prostate cancer 
Answer:
 Disease: metastatic prostate cancer